SARS-CoV-2 seroprevalence among blood donors, Chongqing, China, January 1 to May 31, 2020.
Shichun Wang, Min Song, Qi Liu, Chunyan Yao
Author Information
- Shichun Wang: Department of Blood Transfusion, First Affiliated Hospital, Third Military Medical University (Army Medical University), Chongqing Blood Bank of the People's Liberation Army, Chongqing, 400038, China.
- Min Song: Department of Blood Transfusion, First Affiliated Hospital, Third Military Medical University (Army Medical University), Chongqing Blood Bank of the People's Liberation Army, Chongqing, 400038, China.
- Qi Liu: Department of Blood Transfusion, First Affiliated Hospital, Third Military Medical University (Army Medical University), Chongqing Blood Bank of the People's Liberation Army, Chongqing, 400038, China.
- Chunyan Yao: Department of Blood Transfusion, First Affiliated Hospital, Third Military Medical University (Army Medical University), Chongqing Blood Bank of the People's Liberation Army, Chongqing, 400038, China; State Key Laboratory of Trauma, Burn and Combined Injury, Third Military Medical University, Chongqing, 400038, China. Electronic address: yao_yao24@yahoo.com.
No abstract text available.
Antibodies, Viral
Blood Donors
COVID-19
Humans
Immunoglobulin G
SARS-CoV-2
Seroepidemiologic Studies
Antibodies, Viral
Immunoglobulin G